Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neuralgia × Yoga × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 21 Fatigue 15 Neoplasms 8 Depression 6 Pain 4 Colorectal Neoplasms 4 Prostatic Neoplasms 3 Glioma 3 Anxiety Disorders 3 Sleep Wake Disorders 2 Sleep Initiation and Maintenance Disorders 2 Polycystic Ovary Syndrome 2 Parasomnias 2 Ovarian Neoplasms 2 Oligodendroglioma 2 Obesity 2 Motor Activity 2 Meningioma 2 Medulloblastoma 2 Lymphedema 2 Lung Neoplasms 2 Leukemia 2 Gliosarcoma 2 Glioblastoma 2 Esophageal Neoplasms 2 Ependymoma 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Brain Neoplasms 2 Astrocytoma 2

Interventions

Pregabalin 4 Lidocaine 4 Bupivacaine 3 ziconotide 2 Transcranial Magnetic Stimulation 2 onabotulinum toxin A 1 Yoga 1 Vitamin B 6 1 Vitamin B 12 1 Vinorelbine 1 Vincristine 1 Thalidomide 1 Telmisartan 1 Surveys and Questionnaires 1 Sodium Chloride 1 Saline Solution 1 Paclitaxel 1 Oxycodone 1 Oxaliplatin 1 Low-Level Light Therapy 1 Lidoderm 1 Ketamine 1 KRN 5500 1 Hospitals 1 Geritol 1 Gabapentin 1 Folfox protocol 1 Exercise Therapy 1 Exercise 1 Electroacupuncture 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05121558 2026-02-06

YCT

Dana-Farber Cancer Institute

Phase NA Active not recruiting

Neuropathy, Painful, Agnosia, Neuralgia, Pain, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡